Share Price and Basic Stock Data
Last Updated: January 2, 2026, 8:49 pm
| PEG Ratio | -2.06 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Vinyl Chemicals (I) Ltd operates in a sector characterized by fluctuating demand and competitive pricing pressures. The company reported sales of ₹1,013 Cr for the fiscal year ending March 2023, a significant increase from ₹865 Cr in the previous year. However, sales for the subsequent fiscal year, ending March 2024, declined to ₹597 Cr, reflecting a contraction in revenue that could raise concerns among investors. The trailing twelve months (TTM) sales stood at ₹622 Cr, indicating a slight recovery compared to the fiscal year 2024. Quarterly sales figures reveal a volatile trend, with the most recent quarter (September 2023) reporting ₹154.40 Cr, an increase from ₹106.93 Cr in March 2023. This pattern suggests potential seasonal fluctuations or market dynamics impacting revenue generation. The company’s ability to stabilize and grow revenues amid these variances will be crucial for maintaining investor interest and market share.
Profitability and Efficiency Metrics
Vinyl Chemicals reported an operating profit margin (OPM) of 1.76%, which is relatively low compared to industry averages, indicating challenges in cost management or pricing power. The OPM has seen fluctuations, with a high of 5.50% in December 2023 but dropping to 1.76% by September 2025. The net profit for the fiscal year 2023 was ₹36 Cr, translating to an earnings per share (EPS) of ₹19.44, which reflects solid profitability despite the operating challenges. Notably, the return on equity (ROE) stood at 15.6%, while the return on capital employed (ROCE) was reported at 21.1%, both indicating effective utilization of equity and capital. However, the company’s interest coverage ratio was exceptionally high at 763.53x, suggesting that interest expenses are negligible, allowing for robust financial flexibility. This financial robustness is necessary for navigating market uncertainties and potential operational challenges ahead.
Balance Sheet Strength and Financial Ratios
Vinyl Chemicals maintains a strong balance sheet with no reported borrowings, reflecting prudent financial management and minimal leverage. The equity capital remains steady at ₹2 Cr, with reserves increasing from ₹111 Cr in March 2023 to ₹125 Cr in March 2025, indicating a focus on retaining earnings for future growth. The company’s book value per share has also shown a positive trend, reaching ₹69.05 in March 2025, compared to ₹61.77 in the previous year. Financial ratios such as the current ratio of 1.93 and quick ratio of 1.46 suggest a healthy liquidity position, enabling the company to meet short-term obligations comfortably. However, the price-to-book value ratio of 4.10x indicates that the stock may be trading at a premium compared to its book value, which could be a concern for value-oriented investors. The company’s overall financial health, characterized by strong liquidity and no debt, positions it well for potential growth opportunities.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Vinyl Chemicals reveals a significant concentration of ownership, with promoters holding 50.41% of the shares. This stability in promoter ownership may instill confidence among investors regarding long-term management commitment. However, the lack of foreign institutional investors (FIIs) and only a 0.02% stake from domestic institutional investors (DIIs) raises questions about broader market confidence in the stock. The number of shareholders has declined from 46,195 in September 2023 to 40,756 in September 2025, indicating potential disenchantment among retail investors. Furthermore, the public holding stood at 49.57%, suggesting that while retail interest is present, it has not translated into significant institutional backing. The overall investor sentiment appears cautious, reflected in the declining number of shareholders, which may impact liquidity and market performance.
Outlook, Risks, and Final Insight
The outlook for Vinyl Chemicals hinges on its ability to navigate revenue volatility and enhance profitability. The company faces risks such as fluctuating raw material prices and competitive pressures that could impact margins. Additionally, the recent decline in sales from ₹1,013 Cr to ₹597 Cr poses a significant risk to sustaining investor confidence. However, the absence of debt and a strong liquidity position provide a buffer against market volatility. If the company can stabilize its revenue streams while improving operational efficiencies, it may regain investor confidence and market traction. Conversely, continued revenue decline coupled with low profitability could lead to further shareholder disenchantment. The management’s strategic focus on cost control and market positioning will be crucial in determining Vinyl Chemicals’ future trajectory in a challenging market environment.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Metallic Coal & Coke Ltd | 5.94 Cr. | 30.0 | / | 77.6 | 0.00 % | 0.37 % | 2.00 % | 100 | |
| Gensol Engineering Ltd | 102 Cr. | 26.6 | 796/25.8 | 1.00 | 155 | 0.00 % | 14.3 % | 22.4 % | 10.0 |
| Fusion Micro Finance Ltd | 1,634 Cr. | 162 | 212/124 | 118 | 0.00 % | 2.96 % | 54.5 % | 10.0 | |
| Five X Tradecom Ltd | 0.99 Cr. | 0.48 | / | 9.35 | 0.00 % | 0.00 % | 0.00 % | 10.0 | |
| East West Holdings Ltd | 46.4 Cr. | 3.64 | 8.19/3.42 | 4.93 | 0.00 % | 6.98 % | 0.86 % | 2.00 | |
| Industry Average | 7,872.43 Cr | 221.88 | 397.35 | 219.27 | 0.25% | 11.73% | 22.92% | 9.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 324.17 | 270.66 | 106.93 | 115.31 | 154.40 | 159.03 | 168.27 | 155.63 | 150.34 | 146.40 | 172.88 | 151.23 | 151.89 |
| Expenses | 311.30 | 260.62 | 97.41 | 111.87 | 149.87 | 150.28 | 159.63 | 149.65 | 144.39 | 142.74 | 162.93 | 149.26 | 149.22 |
| Operating Profit | 12.87 | 10.04 | 9.52 | 3.44 | 4.53 | 8.75 | 8.64 | 5.98 | 5.95 | 3.66 | 9.95 | 1.97 | 2.67 |
| OPM % | 3.97% | 3.71% | 8.90% | 2.98% | 2.93% | 5.50% | 5.13% | 3.84% | 3.96% | 2.50% | 5.76% | 1.30% | 1.76% |
| Other Income | 0.70 | 0.16 | 0.99 | 1.26 | 0.82 | 0.64 | 1.73 | 0.78 | 1.05 | 2.99 | 0.19 | 4.09 | 1.27 |
| Interest | 0.15 | 0.17 | 0.94 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.03 |
| Depreciation | 0.03 | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 |
| Profit before tax | 13.39 | 10.01 | 9.54 | 4.66 | 5.31 | 9.36 | 10.33 | 6.73 | 6.95 | 6.61 | 10.11 | 6.02 | 3.88 |
| Tax % | 24.94% | 26.37% | 23.48% | 24.89% | 26.93% | 25.96% | 27.11% | 26.89% | 26.19% | 24.21% | 28.09% | 26.08% | 25.77% |
| Net Profit | 10.05 | 7.37 | 7.30 | 3.50 | 3.88 | 6.93 | 7.53 | 4.92 | 5.13 | 5.01 | 7.27 | 4.45 | 2.88 |
| EPS in Rs | 5.48 | 4.02 | 3.98 | 1.91 | 2.12 | 3.78 | 4.11 | 2.68 | 2.80 | 2.73 | 3.96 | 2.43 | 1.57 |
Last Updated: December 28, 2025, 2:02 pm
Below is a detailed analysis of the quarterly data for Vinyl Chemicals (I) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 151.89 Cr.. The value appears strong and on an upward trend. It has increased from 151.23 Cr. (Jun 2025) to 151.89 Cr., marking an increase of 0.66 Cr..
- For Expenses, as of Sep 2025, the value is 149.22 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 149.26 Cr. (Jun 2025) to 149.22 Cr., marking a decrease of 0.04 Cr..
- For Operating Profit, as of Sep 2025, the value is 2.67 Cr.. The value appears strong and on an upward trend. It has increased from 1.97 Cr. (Jun 2025) to 2.67 Cr., marking an increase of 0.70 Cr..
- For OPM %, as of Sep 2025, the value is 1.76%. The value appears strong and on an upward trend. It has increased from 1.30% (Jun 2025) to 1.76%, marking an increase of 0.46%.
- For Other Income, as of Sep 2025, the value is 1.27 Cr.. The value appears to be declining and may need further review. It has decreased from 4.09 Cr. (Jun 2025) to 1.27 Cr., marking a decrease of 2.82 Cr..
- For Interest, as of Sep 2025, the value is 0.03 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.01 Cr. (Jun 2025) to 0.03 Cr., marking an increase of 0.02 Cr..
- For Depreciation, as of Sep 2025, the value is 0.03 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.03 Cr..
- For Profit before tax, as of Sep 2025, the value is 3.88 Cr.. The value appears to be declining and may need further review. It has decreased from 6.02 Cr. (Jun 2025) to 3.88 Cr., marking a decrease of 2.14 Cr..
- For Tax %, as of Sep 2025, the value is 25.77%. The value appears to be improving (decreasing) as expected. It has decreased from 26.08% (Jun 2025) to 25.77%, marking a decrease of 0.31%.
- For Net Profit, as of Sep 2025, the value is 2.88 Cr.. The value appears to be declining and may need further review. It has decreased from 4.45 Cr. (Jun 2025) to 2.88 Cr., marking a decrease of 1.57 Cr..
- For EPS in Rs, as of Sep 2025, the value is 1.57. The value appears to be declining and may need further review. It has decreased from 2.43 (Jun 2025) to 1.57, marking a decrease of 0.86.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:24 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 293 | 442 | 335 | 293 | 375 | 483 | 372 | 404 | 865 | 1,013 | 597 | 625 | 622 |
| Expenses | 282 | 424 | 326 | 283 | 361 | 469 | 366 | 389 | 821 | 966 | 572 | 600 | 604 |
| Operating Profit | 10 | 18 | 9 | 9 | 14 | 14 | 6 | 15 | 44 | 47 | 25 | 26 | 18 |
| OPM % | 4% | 4% | 3% | 3% | 4% | 3% | 2% | 4% | 5% | 5% | 4% | 4% | 3% |
| Other Income | 1 | 1 | 3 | 4 | 4 | 1 | 4 | 0 | 2 | 2 | 4 | 5 | 9 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 11 | 19 | 12 | 13 | 18 | 14 | 10 | 15 | 47 | 48 | 30 | 30 | 27 |
| Tax % | 34% | 34% | 35% | 35% | 36% | 37% | 25% | 26% | 25% | 25% | 26% | 27% | |
| Net Profit | 7 | 12 | 8 | 9 | 12 | 9 | 7 | 11 | 35 | 36 | 22 | 22 | 20 |
| EPS in Rs | 4.08 | 6.73 | 4.36 | 4.76 | 6.36 | 4.83 | 4.07 | 6.19 | 19.01 | 19.44 | 11.91 | 12.18 | 10.69 |
| Dividend Payout % | 24% | 22% | 34% | 38% | 38% | 50% | 59% | 60% | 52% | 51% | 57% | 57% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 71.43% | -33.33% | 12.50% | 33.33% | -25.00% | -22.22% | 57.14% | 218.18% | 2.86% | -38.89% | 0.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -104.76% | 45.83% | 20.83% | -58.33% | 2.78% | 79.37% | 161.04% | -215.32% | -41.75% | 38.89% |
Vinyl Chemicals (I) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 11% |
| 3 Years: | -10% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 24% |
| 3 Years: | -17% |
| TTM: | -6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 25% |
| 3 Years: | -18% |
| 1 Year: | -28% |
| Return on Equity | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 24% |
| 3 Years: | 21% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 1:51 pm
Balance Sheet
Last Updated: December 4, 2025, 2:12 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Reserves | 24 | 33 | 41 | 46 | 54 | 57 | 59 | 66 | 94 | 111 | 115 | 125 | 119 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Other Liabilities | 80 | 69 | 80 | 56 | 115 | 84 | 94 | 200 | 65 | 62 | 188 | 135 | 86 |
| Total Liabilities | 106 | 104 | 123 | 104 | 171 | 144 | 156 | 269 | 162 | 176 | 305 | 262 | 207 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 5 | 9 | 45 | 39 | 34 | 2 | 47 | 55 | 78 | 40 | 57 | 68 | 0 |
| Other Assets | 100 | 95 | 78 | 66 | 137 | 141 | 108 | 214 | 84 | 135 | 247 | 193 | 206 |
| Total Assets | 106 | 104 | 123 | 104 | 171 | 144 | 156 | 269 | 162 | 176 | 305 | 262 | 207 |
Below is a detailed analysis of the balance sheet data for Vinyl Chemicals (I) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
- For Reserves, as of Sep 2025, the value is 119.00 Cr.. The value appears to be declining and may need further review. It has decreased from 125.00 Cr. (Mar 2025) to 119.00 Cr., marking a decrease of 6.00 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 86.00 Cr.. The value appears to be improving (decreasing). It has decreased from 135.00 Cr. (Mar 2025) to 86.00 Cr., marking a decrease of 49.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 207.00 Cr.. The value appears to be improving (decreasing). It has decreased from 262.00 Cr. (Mar 2025) to 207.00 Cr., marking a decrease of 55.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 68.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 68.00 Cr..
- For Other Assets, as of Sep 2025, the value is 206.00 Cr.. The value appears strong and on an upward trend. It has increased from 193.00 Cr. (Mar 2025) to 206.00 Cr., marking an increase of 13.00 Cr..
- For Total Assets, as of Sep 2025, the value is 207.00 Cr.. The value appears to be declining and may need further review. It has decreased from 262.00 Cr. (Mar 2025) to 207.00 Cr., marking a decrease of 55.00 Cr..
Notably, the Reserves (119.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 10.00 | 18.00 | 9.00 | 9.00 | 14.00 | 14.00 | 6.00 | 15.00 | 43.00 | 47.00 | 25.00 | 26.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 66 | 40 | 54 | 57 | 75 | 48 | 45 | 100 | 5 | 11 | 65 | 61 |
| Inventory Days | 48 | 33 | 29 | 23 | 57 | 53 | 50 | 70 | 24 | 33 | 78 | 39 |
| Days Payable | 99 | 53 | 88 | 69 | 116 | 63 | 95 | 188 | 26 | 22 | 118 | 78 |
| Cash Conversion Cycle | 15 | 20 | -5 | 11 | 17 | 39 | -1 | -17 | 3 | 22 | 25 | 23 |
| Working Capital Days | 16 | 19 | -4 | 10 | 19 | 36 | 2 | 2 | 7 | 26 | 32 | 27 |
| ROCE % | 45% | 57% | 24% | 21% | 30% | 24% | 14% | 23% | 55% | 44% | 22% | 21% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 12.17 | 11.91 | 19.44 | 19.01 | 6.19 |
| Diluted EPS (Rs.) | 12.17 | 11.91 | 19.44 | 19.01 | 6.19 |
| Cash EPS (Rs.) | 12.23 | 11.96 | 19.49 | 19.01 | 6.19 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 69.05 | 63.66 | 61.77 | 52.35 | 37.12 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 69.05 | 63.66 | 61.77 | 52.35 | 37.12 |
| Dividend / Share (Rs.) | 7.00 | 6.75 | 10.00 | 10.00 | 3.75 |
| Revenue From Operations / Share (Rs.) | 340.85 | 325.45 | 551.96 | 471.58 | 220.32 |
| PBDIT / Share (Rs.) | 16.65 | 16.25 | 26.70 | 25.54 | 8.34 |
| PBIT / Share (Rs.) | 16.59 | 16.20 | 26.64 | 25.54 | 8.34 |
| PBT / Share (Rs.) | 16.57 | 16.17 | 25.91 | 25.45 | 8.31 |
| Net Profit / Share (Rs.) | 12.17 | 11.91 | 19.43 | 19.01 | 6.19 |
| PBDIT Margin (%) | 4.88 | 4.99 | 4.83 | 5.41 | 3.78 |
| PBIT Margin (%) | 4.86 | 4.97 | 4.82 | 5.41 | 3.78 |
| PBT Margin (%) | 4.86 | 4.96 | 4.69 | 5.39 | 3.77 |
| Net Profit Margin (%) | 3.57 | 3.65 | 3.52 | 4.03 | 2.80 |
| Return on Networth / Equity (%) | 17.63 | 18.70 | 31.45 | 36.30 | 16.67 |
| Return on Capital Employeed (%) | 23.89 | 25.29 | 42.84 | 48.43 | 22.12 |
| Return On Assets (%) | 8.51 | 7.15 | 20.29 | 21.56 | 4.22 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Asset Turnover Ratio (%) | 2.20 | 2.48 | 6.00 | 4.02 | 1.90 |
| Current Ratio (X) | 1.93 | 1.62 | 2.83 | 2.47 | 1.34 |
| Quick Ratio (X) | 1.46 | 0.97 | 1.46 | 1.66 | 0.97 |
| Inventory Turnover Ratio (X) | 6.83 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 55.42 | 83.94 | 51.44 | 19.72 | 38.76 |
| Dividend Payout Ratio (CP) (%) | 55.17 | 83.55 | 51.29 | 19.72 | 38.74 |
| Earning Retention Ratio (%) | 44.58 | 16.06 | 48.56 | 80.28 | 61.24 |
| Cash Earning Retention Ratio (%) | 44.83 | 16.45 | 48.71 | 80.28 | 61.26 |
| Interest Coverage Ratio (X) | 763.53 | 611.00 | 36.23 | 283.98 | 329.54 |
| Interest Coverage Ratio (Post Tax) (X) | 559.34 | 448.62 | 27.37 | 212.29 | 245.55 |
| Enterprise Value (Cr.) | 507.69 | 574.53 | 612.80 | 480.31 | 201.52 |
| EV / Net Operating Revenue (X) | 0.81 | 0.96 | 0.60 | 0.55 | 0.49 |
| EV / EBITDA (X) | 16.62 | 19.27 | 12.51 | 10.25 | 13.17 |
| MarketCap / Net Operating Revenue (X) | 0.82 | 0.97 | 0.60 | 0.55 | 0.52 |
| Retention Ratios (%) | 44.57 | 16.05 | 48.55 | 80.27 | 61.23 |
| Price / BV (X) | 4.10 | 4.97 | 5.42 | 5.01 | 3.13 |
| Price / Net Operating Revenue (X) | 0.82 | 0.97 | 0.60 | 0.55 | 0.52 |
| EarningsYield | 0.04 | 0.03 | 0.05 | 0.07 | 0.05 |
After reviewing the key financial ratios for Vinyl Chemicals (I) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 12.17. This value is within the healthy range. It has increased from 11.91 (Mar 24) to 12.17, marking an increase of 0.26.
- For Diluted EPS (Rs.), as of Mar 25, the value is 12.17. This value is within the healthy range. It has increased from 11.91 (Mar 24) to 12.17, marking an increase of 0.26.
- For Cash EPS (Rs.), as of Mar 25, the value is 12.23. This value is within the healthy range. It has increased from 11.96 (Mar 24) to 12.23, marking an increase of 0.27.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 69.05. It has increased from 63.66 (Mar 24) to 69.05, marking an increase of 5.39.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 69.05. It has increased from 63.66 (Mar 24) to 69.05, marking an increase of 5.39.
- For Dividend / Share (Rs.), as of Mar 25, the value is 7.00. This value exceeds the healthy maximum of 3. It has increased from 6.75 (Mar 24) to 7.00, marking an increase of 0.25.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 340.85. It has increased from 325.45 (Mar 24) to 340.85, marking an increase of 15.40.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 16.65. This value is within the healthy range. It has increased from 16.25 (Mar 24) to 16.65, marking an increase of 0.40.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.59. This value is within the healthy range. It has increased from 16.20 (Mar 24) to 16.59, marking an increase of 0.39.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.57. This value is within the healthy range. It has increased from 16.17 (Mar 24) to 16.57, marking an increase of 0.40.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 12.17. This value is within the healthy range. It has increased from 11.91 (Mar 24) to 12.17, marking an increase of 0.26.
- For PBDIT Margin (%), as of Mar 25, the value is 4.88. This value is below the healthy minimum of 10. It has decreased from 4.99 (Mar 24) to 4.88, marking a decrease of 0.11.
- For PBIT Margin (%), as of Mar 25, the value is 4.86. This value is below the healthy minimum of 10. It has decreased from 4.97 (Mar 24) to 4.86, marking a decrease of 0.11.
- For PBT Margin (%), as of Mar 25, the value is 4.86. This value is below the healthy minimum of 10. It has decreased from 4.96 (Mar 24) to 4.86, marking a decrease of 0.10.
- For Net Profit Margin (%), as of Mar 25, the value is 3.57. This value is below the healthy minimum of 5. It has decreased from 3.65 (Mar 24) to 3.57, marking a decrease of 0.08.
- For Return on Networth / Equity (%), as of Mar 25, the value is 17.63. This value is within the healthy range. It has decreased from 18.70 (Mar 24) to 17.63, marking a decrease of 1.07.
- For Return on Capital Employeed (%), as of Mar 25, the value is 23.89. This value is within the healthy range. It has decreased from 25.29 (Mar 24) to 23.89, marking a decrease of 1.40.
- For Return On Assets (%), as of Mar 25, the value is 8.51. This value is within the healthy range. It has increased from 7.15 (Mar 24) to 8.51, marking an increase of 1.36.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.20. It has decreased from 2.48 (Mar 24) to 2.20, marking a decrease of 0.28.
- For Current Ratio (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has increased from 1.62 (Mar 24) to 1.93, marking an increase of 0.31.
- For Quick Ratio (X), as of Mar 25, the value is 1.46. This value is within the healthy range. It has increased from 0.97 (Mar 24) to 1.46, marking an increase of 0.49.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.83. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 6.83, marking an increase of 6.83.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 55.42. This value exceeds the healthy maximum of 50. It has decreased from 83.94 (Mar 24) to 55.42, marking a decrease of 28.52.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 55.17. This value exceeds the healthy maximum of 50. It has decreased from 83.55 (Mar 24) to 55.17, marking a decrease of 28.38.
- For Earning Retention Ratio (%), as of Mar 25, the value is 44.58. This value is within the healthy range. It has increased from 16.06 (Mar 24) to 44.58, marking an increase of 28.52.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 44.83. This value is within the healthy range. It has increased from 16.45 (Mar 24) to 44.83, marking an increase of 28.38.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 763.53. This value is within the healthy range. It has increased from 611.00 (Mar 24) to 763.53, marking an increase of 152.53.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 559.34. This value is within the healthy range. It has increased from 448.62 (Mar 24) to 559.34, marking an increase of 110.72.
- For Enterprise Value (Cr.), as of Mar 25, the value is 507.69. It has decreased from 574.53 (Mar 24) to 507.69, marking a decrease of 66.84.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.81. This value is below the healthy minimum of 1. It has decreased from 0.96 (Mar 24) to 0.81, marking a decrease of 0.15.
- For EV / EBITDA (X), as of Mar 25, the value is 16.62. This value exceeds the healthy maximum of 15. It has decreased from 19.27 (Mar 24) to 16.62, marking a decrease of 2.65.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. It has decreased from 0.97 (Mar 24) to 0.82, marking a decrease of 0.15.
- For Retention Ratios (%), as of Mar 25, the value is 44.57. This value is within the healthy range. It has increased from 16.05 (Mar 24) to 44.57, marking an increase of 28.52.
- For Price / BV (X), as of Mar 25, the value is 4.10. This value exceeds the healthy maximum of 3. It has decreased from 4.97 (Mar 24) to 4.10, marking a decrease of 0.87.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. It has decreased from 0.97 (Mar 24) to 0.82, marking a decrease of 0.15.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Vinyl Chemicals (I) Ltd:
- Net Profit Margin: 3.57%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 23.89% (Industry Average ROCE: 11.73%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.63% (Industry Average ROE: 22.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 559.34
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.46
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 22.4 (Industry average Stock P/E: 397.35)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.57%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | Regent Chambers, 7th Floor, Mumbai Maharashtra 400021 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. M B Parekh | Chairman & Managing Director |
| Mr. N K Parekh | Director |
| Mr. A B Parekh | Director |
| Mr. P D Shah | Director |
| Mr. L Viswanathan | Director |
| Mrs. Shailashri Bhaskar | Director |
FAQ
What is the intrinsic value of Vinyl Chemicals (I) Ltd?
Vinyl Chemicals (I) Ltd's intrinsic value (as of 03 January 2026) is ₹190.16 which is 21.10% lower the current market price of ₹241.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹438 Cr. market cap, FY2025-2026 high/low of ₹366/215, reserves of ₹119 Cr, and liabilities of ₹207 Cr.
What is the Market Cap of Vinyl Chemicals (I) Ltd?
The Market Cap of Vinyl Chemicals (I) Ltd is 438 Cr..
What is the current Stock Price of Vinyl Chemicals (I) Ltd as on 03 January 2026?
The current stock price of Vinyl Chemicals (I) Ltd as on 03 January 2026 is ₹241.
What is the High / Low of Vinyl Chemicals (I) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Vinyl Chemicals (I) Ltd stocks is ₹366/215.
What is the Stock P/E of Vinyl Chemicals (I) Ltd?
The Stock P/E of Vinyl Chemicals (I) Ltd is 22.4.
What is the Book Value of Vinyl Chemicals (I) Ltd?
The Book Value of Vinyl Chemicals (I) Ltd is 66.1.
What is the Dividend Yield of Vinyl Chemicals (I) Ltd?
The Dividend Yield of Vinyl Chemicals (I) Ltd is 2.91 %.
What is the ROCE of Vinyl Chemicals (I) Ltd?
The ROCE of Vinyl Chemicals (I) Ltd is 21.1 %.
What is the ROE of Vinyl Chemicals (I) Ltd?
The ROE of Vinyl Chemicals (I) Ltd is 15.6 %.
What is the Face Value of Vinyl Chemicals (I) Ltd?
The Face Value of Vinyl Chemicals (I) Ltd is 1.00.